Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT06962605
Recruiting Not applicable

Effects of Intermittent Running on Metabolic Health

NCT06962605 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-06-21
Last updated
2026-01-26

Condition(s) studied

Metabolic RegulationEnergy Expenditure

Investigational drug(s) / intervention(s)

Moderate-intensity continuous running (MICE: 60% V̇O2max)5-minute interval running (5MIN)2-minute interval running (2MIN)

Moderate-intensity continuous running (MICE: 60% V̇O2max): Participants run continuously for 40 minutes at moderate intensity (60-65% V̇O2max)

5-minute interval running (5MIN): Participants run for 40 minutes at average moderate intensity with 5-minutes slow and fast cycles where speed is increased and decreased by 20%.

2-minute interval running (2MIN): Participants run for 40 minutes at average moderate intensity with 2-minutes slow and fast cycles where speed is increased and decreased by 20%.

Study summary

The purpose of this study is to investigate the suitability of intermittent exercise of long and short intervals at lower intensities than HIIE on energy expenditure during and post-exercise compared to MICE, as well as determine whether similar or greater effects can be achieved for glycemic control in recreationally active adults.

Eligibility

Sex
MALE
Min age
20 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy recreationally active men * BMI between 18.5-27 kg/m2 * Aged between 20 to 45 years * Regular exercise (3 times per week and longer than 3 months) with cardio exercise longer than 30 minutes at least once a week * Weight stable for more than 3 months (no change in weight +/- 3%) * Non-shift workers and sleep at least 6.5-9 hours for the past 3 months * Non-smoker Exclusion Criteria: * having any cardiovascular, metabolic or pulmonary disease (angina pectoris or uncontrolled arrhythmias) * suffering from infectious contagious diseases, * using medications that could affect metabolic responses (including anti-inflammatory medications) * smoking * heavy alcohol intake (more than 4 drinks on any day or more than 14 drinks a week). * undergoing special diets (e.g., intermittent fasting and/or ketogenic diets)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Taiwan Normal University Taipei Taiwan Recruiting

More National Taiwan Normal University trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06962605 on ClinicalTrials.gov ↗ ← All trials in Taiwan